Figure 6
Figure 6. TAB2 activates TAK1 in the endothelium. (A) TAK1 control (Tak1flox/flox; TAK1 CT) and Rosa26-Cre Tak1flox/flox (TAK1iko) mice were treated with tamoxifen and lung endothelial cells were purified by magnetic beads coated with PECAM-1 Ab. The purified endothelial cells were analyzed by immunoblotting. (B) Lung endothelial cells from TAB2 control (Tab2flox/flox; TAB2 CT) and Rosa26-Cre Tab2flox/flox (TAB2iko) mice were analyzed by immunoblotting. (C) Cell lysates from control TNFR1−/− (Tak1flox/flox Tnfr1−/−) and TAK1ecko TNFR1−/− (Tie2-Cre Tak1flox/flox Tnfr1−/−) yolk sacs at E10.5 were analyzed by immunoblotting. (D) Cell lysates from TNFR1−/− (Tab2flox/flox Tnfr1−/−) and TAB2ecko TNFR1−/− (Tie2-Cre Tab2flox/flox Tnfr1−/−) yolk sacs at E11.5 and E12.5, respectively, were analyzed by immunoblotting. One control and 2 TAB2ecko TNFR1−/− embryos from the same litter were analyzed. Molecular weight markers are shown (kDa). Asterisks indicate nonspecific bands.

TAB2 activates TAK1 in the endothelium. (A) TAK1 control (Tak1flox/flox; TAK1 CT) and Rosa26-Cre Tak1flox/flox (TAK1iko) mice were treated with tamoxifen and lung endothelial cells were purified by magnetic beads coated with PECAM-1 Ab. The purified endothelial cells were analyzed by immunoblotting. (B) Lung endothelial cells from TAB2 control (Tab2flox/flox; TAB2 CT) and Rosa26-Cre Tab2flox/flox (TAB2iko) mice were analyzed by immunoblotting. (C) Cell lysates from control TNFR1−/− (Tak1flox/flox Tnfr1−/−) and TAK1ecko TNFR1−/− (Tie2-Cre Tak1flox/flox Tnfr1−/−) yolk sacs at E10.5 were analyzed by immunoblotting. (D) Cell lysates from TNFR1−/− (Tab2flox/flox Tnfr1−/−) and TAB2ecko TNFR1−/− (Tie2-Cre Tab2flox/flox Tnfr1−/−) yolk sacs at E11.5 and E12.5, respectively, were analyzed by immunoblotting. One control and 2 TAB2ecko TNFR1−/− embryos from the same litter were analyzed. Molecular weight markers are shown (kDa). Asterisks indicate nonspecific bands.

Close Modal

or Create an Account

Close Modal
Close Modal